Lilly CEO Plans Dozen-Plus ‘Unmet Needs’ Drugs In China Next Five Years
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly & Co. plans to launch more than a dozen drugs in China over the next five years as part of an effort to become the nation’s fastest-growing drug maker.